European Journal of Pain
© European Pain Federation - EFIC ®
Editor-in-Chief: Luis Garcia-Larrea, Lyon, France
Impact Factor: 2.9
ISI Journal Citation Reports © Ranking: 2015: 9/31 (Anesthesiology); 66/193 (Clinical Neurology); 118/256 (Neurosciences)
Online ISSN: 1532-2149
Associated Title(s): European Journal of Pain Supplements
We would like to inform our authors that we now detect plagiarism easily. The journal to which you are submitting your manuscript employs the CrossCheck plagiarism screening system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works
Ethical policy and guidelines
European Journal of Pain encourages its contributors and reviewers to adopt the standards of the International Committee of Medical Journal Editors.
European Journal of Pain will not consider papers that have been accepted for publication or published elsewhere. Copies of existing manuscripts with potentially overlapping or duplicative material should be submitted together with the manuscript, so that the Editors can judge suitability for publication. The Editors reserve the right to reject a paper on ethical grounds.
Aims and Scope
Online Submission [required]
CONSORT checklist [required for RCTs in patients]
PRISMA checklist [required for systematic reviews/meta-analyses]
Open Access payment form [optional]
Contact the Editorial Office
Instructions for Authors
Article types and content
Letters to the editor
Randomized Controlled (Clinical) Trials
Open label studies
Translation of questionnaires
Studies on health economics
Submission of manuscripts
Preparation of manuscripts
Manuscript structure and word count
Supplementary material to be published online-only
Units & abbreviations
Additional information on acceptance
Further editorial notes and policies
Faculty of 1000
Changes of authorship
Table of content of the European Journal of Pain:
- Editorials and Commentaries
- Position Papers and Guidelines
- Original Research
Prior to submission, please ensure that your manuscript is in accordance with the author guidelines below.
Articles must be submitted online via the European Journal of Pain (EJP) Editorial Manager Site - http://www.editorialmanager.com/eurjpain (see Section 3).
Any queries regarding the scope of the journal, the preparation of manuscripts or the submission of manuscripts may be sent to the Editorial Office at email@example.com
Original Articles are the journal's primary mode of communication.
Original articles must include a structured abstract including at the end a statement “Significance”, indicating the main aspects where this work adds significantly to existing knowledge in the field, and if appropriate to clinical practice. The signifiance statement should be both attention-grabbing and rigorously in line with the contents of the full article ' (see Section 4).
The journal aims to publish concise, topical, high-quality Review Articles of recent advances in laboratory or clinical research. Review Articles may be solicited by the Editor-in-Chief or may be submitted by authors. Any topic will be considered, but priority will be given to those addressing a major current problem and those with up-to-date literature reviews. All Review Articles are subject to peer-review.
Review articles must include a structured abstract including at the end a statement “Significance” in answer to the question 'what does this study add?' (see Section 4). Submission of a completed PRISMA checklist is required for all systematic reviews/meta-analyses.
Short Communications typically describe completed laboratory or clinical work. The guidelines for the preparation of Short Communications are the same as those for Original Articles, as far as applicable. The abstract is limited to 250 words and the body of the article should not exceed three printed pages. Full length articles are preferred and Short Communications will only be accepted if they are of broad interest. Generally, no pilot studies or preliminary results will be accepted.
Commentaries may provide opinion on published findings or on topics pertinent to the community of pain practitioners and researchers. Commentaries are typically commissioned by the Editors. However, suggestions for such articles are welcomed and should be directed to the Editorial Office. A commentary on a paper accepted or already published by EJP must cite the primary article.
Letters to the Editor
Letters to the Editor may be in response to issues arising from recently published articles, or as an exception, short, free-standing pieces expressing an opinion. Letters to the Editor should be formatted in one continuous section and should not exceed one printed page (800 words and 10 references). All letters are subject to peer-review.
Letters in response to a previously published article must cite the original article. At the Editors’ discretion, a letter may be sent to authors of the original paper for comment, and both letter and reply may be published together.
Manuscripts reporting randomised controlled trials [RCTs] must follow the CONSORT statement. RCTs will not be considered by EJP without submission of a completed CONSORT checklist. In addition, authors should consider describing the outcome measures following the IMMPACT recommendations (Dworkin et al., Pain 2005:113;9–19). For clinical trials the Clinical Study Registration Numbers has to be given. Please add this information at the end of your manuscript, before the reference list.
While EJP has a strong focus on quantitative research, qualitative studies are also published. However, qualitative reports will only be considered for publication if they address research questions which are new or have not been extensively addressed in the empirical-quantitative literature. The findings must provide new insights..
Open Label Studies
Open label studies are occasionally considered if the topic is particularly interesting and a controlled study was impracticable.
Translations of Questionnaires
Translations of questionnaires into another language will not be considered for publication except if the study provides information and insights that go beyond the issue of translation and are of interest for international readers. Such data include for example comprehensive validity analyses including factorial validity, divergent and convergent validity or findings with regard to the clinical usefulness of a particular questionnaire.
Studies on Health Economics
Generally this journal does not publish papers on economical aspects of particular forms of pain treatments.
Single case reports are very rarely published, series of case reports might be published if they are of broad interest.
Audits are not published in the European Journal of Pain.
All submissions should be made online at the EJP Editorial Manager site - http://www.editorialmanager.com/eurjpain. New users will be required to register and create an account. Once a user is logged onto the site, submissions should be made via the Author Centre.
Manuscripts must be written in English.
Manuscript text must be saved in Word (.doc) or Rich Text Format (.rtf). Please do not submit text in PDF format (.pdf).
Due to space restrictions and a better readability papers generally should not exceed ten typeset pages (780 words/page, 32 references/page, including figures and tables). EJP can publish additional material as "supporting material" with a special link guiding from the manuscript to this material. Authors are encouraged to take advantage of the online-only publication option.
Suggestions for the cover inset are invited. The illustration may be from a manuscript accepted for publication in the European Journal of Pain.
Manuscript Structure and Word Count
• Title page (see further details below)
• Abstract (should not exceed 250 words, see further details below)
o Introduction (no subheadings, should not exceed 500 words)
o Methods (or Literature Search Methods for Review Articles)
o Discussion and conclusions (should not exceed 1500 words)
• Author contributions (see Section 6)
• References (limited to 80 for original manuscripts)
• Legends for illustrations and tables
2) Tables (to be uploaded as separate files)
3) Figures (to be uploaded as separate files)
4) Supporting material (additional material that will be published online-only, to be uploaded separately, see further details below)
The title page should give:
1) The title of the article. Titles should be short and should not contain acronyms
2) A running head not exceeding 50 characters
3) The authors' names (initial(s) of first name(s) and last name of each author)
4) The names of the institutions at which the research was conducted, clearly linked to respective authors
5) The name, address, telephone and fax numbers, and e-mail address of the author responsible for correspondence
6) The category for which the manuscript is being submitted (original article, review, short communication)
7) A statement of all funding sources that supported the work
8) Any conflicts of interest disclosures (see Section 6).
9) A statement “Significance”, indicating the main aspects where this work adds significantly to existing knowledge in the field, and if appropriate to clinical practice. The signifiance statement should be both attention-grabbing and rigorously in line with the contents of the full article. It should not exceed 50 words and will be added to the end of the abstract at the time of typesetting. It does not count to thte abstract's word limit (250 words)..
The abstract should not exceed 250 words and should describe the background, the aims, the methods, the results and the conclusions reached. It should contain only standard abbreviations and no references. The short statement "Significance" (see above) needs to be added at the end of the abstract, giving some information about what this study/this review adds, what are the new findings (max. 40 words). For Original Manuscripts the following subheadings are required:
For Reviews the following subheadings are required:
• Background and Objective
• Databases and Data Treatment
The statement "Significance" that has to be given on the title page will be added at the end of the abstract at the time of typesetting. It does not count to the abstract's word limit (250 words).
The acknowledgements section should specify acknowledgement of technical help, but no sources of financial and material support. These should be given in the "Funding Sources" on the Title page.
Authors are required to include a statement of responsibility at the end of their manuscript's text that specifies the contribution of every author (see Section 6). Please state that all authors discussed the results and commented on the manuscript.
In the text: references should be cited in parantheses at the appropriate point in the text by author(s) and year in chronological order, e.g., (Mustola, 1996; Baer, 1997; Mustola and Baer, 1998; Mustola et al., 1999). If two or more references with the same first author and year are cited, use lower-case letters a, b, etc., after the year both in the text and in the reference list.
In the reference list: references to cited materials should be listed in alphabetical order at the end of the article. Please use Index Medicus abbreviations for journal titles. Include all authors. Whenever the author list in a reference exceeeds 8 authors, please keep the first 5 names then add "et al ".
Example for an article in a periodical:
De Peuter, S., Van Diest, I., Vansteenwegen, D. (2011). Understanding fear of pain in chronic pain: Interoceptive fear conditioning as a novel approach. Eur J Pain 15,889–894.
Example for a chapter in a book:
Janes, R., Saarto, T. (2010). Oncologic therapy in cancer pain. In Evidence-Based Chronic Pain Management, C. Stannard, E. Kalso, J. Ballantyne, eds. (Oxford: Wiley-Blackwell) pp. 311–326.
Example for a book:
Van Zundert, J., Patijn, J., Hartrick, C. (2011). Evidence-based Interventional Pain Practice (Oxford: Wiley-Blackwell).
Citing and listing of Web references:
As a minimum, the full URL should be given. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web references should be listed separately (e.g., after the reference list) under the heading "Web references".
Personal communications, manuscripts in preparation and other unpublished data should not be cited in the reference list but may be mentioned in the text in parentheses.
All colour illustrations will be published free of charge.
All figures must be uploaded as separate files. Figure legends should be listed on a separate page in numerical order and should contain brief but comprehensible explanations.
Figures should be referred to in the text in numerical sequence as follows: Fig. 1, Figs 2–4. The place at which a figure is to be inserted in the printed text should be indicated clearly on a manuscript. Where a figure has more than one panel, each panel should be labeled in the top left-hand corner using lower case letters in parentheses i.e. ‘(a)’, ‘(b)’ etc., and a brief description of each panel given in the figure legend.
Authors are themselves responsible for obtaining permission to reproduce previously published figures or tables. When an individual is identifiable in a photograph written consent must be obtained. This permission must include the right to publish in electronic media.
Print publication requires high quality, EPS (lineart) or TIFF/PDF (halftone/photographs) files are preferable (though GIF, JPEG, PICT or Bitmap files are acceptable for submission). MS PowerPoint and Word Graphics are unsuitable for printed pictures. Scans (TIFF only) should have a resolution of 300 dpi (halftone) or 600 to 1200 dpi (line drawings) in relation to the reproduction size (see below). EPS files should be saved with fonts embedded (and with a TIFF preview if possible). For scanned images, the scanning resolution (at final image size) should be as follows to ensure good reproduction: lineart: >600 dpi; half-tones: >300 dpi; figures containing both halftone and line images: >600 dpi.
Detailed instructions for electronic artwork preparation may be found at http://authorservices.wiley.com/bauthor/illustration.asp.
Tables should be referred to in the text in numerical sequence as follows: Table 1, Table 2. Each table, with an appropriate brief legend, comprehensible without reference to the text, should be typed on a separate page. For footnotes, use superscripts 'a', 'b', 'c', etc., not asterisks or other symbols.
EJP encourages the submission of underlying data sets, appendices, additional figures or tables, movie files, animations, etc. as online supporting information. Supporting information should be uploaded during manuscript submission (see Section 3). Supporting information should be important ancillary information that is relevant to the parent article but which is not included in the typeset PDF but can be accessed via a link from this PDF.
To submit any material to be published as supporting material please choose the item "supporting information when uploading the files of tables or figures.
Please use the following terms:
- for tables: "tableS1", "tableS2" etc.
- for figures: "figureS1, "figureS2" etc. The figure legends should be included in the figure's file.
- for parts of the manuscript's text: "methodsS1", resultsS1", "discussionS1" or "AppendixS1" (please note that it is not possible to publish additional material for the introduction)
- please indicate and cite clearly in your manuscript the supporting information using the terms given above.
Units & Abbreviations
Measurements of length, height and volume should be reported in metric units (metre, kilogram, litre). Temperatures should be given in degrees Celsius and blood pressures in millimetres of mercury or kPa with the alternative units in parentheses. All other measurements including laboratory measurements should be reported in the metric system in terms of the International System of Units (SI).
Generic names of drugs should be used where possible. When quoting from specific materials on proprietary drugs, authors must state in parentheses the name and address of the manufacturer.
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
For Authors Signing the Copyright Transfer Agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp
For Authors Choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) or the Austrian Science Fund (FWF) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with your Funder requirements. Correctly indicating your funders helps ensure compliance with license mandates. Learn more on Wiley’s Funder Agreements page.
Page proofs will be sent electronically to the corresponding author and should be returned within 3 days of receipt to the Production Editor. Significant textual alterations are unacceptable at proof stage without the written approval of the Editor, and they are likely to result in the delay of publication.
The corresponding author will receive an e-mail alert containing a link to a secure web site. A working e-mail address must therefore be provided for the corresponding author. In the absence of the corresponding author, please arrange for a colleague to access the e-mail to retrieve the proofs.
Please note that you have final responsibility for what is stated in the proofs of your manuscript. However, the proofs are checked thoroughly by the EJP editorial team and if we do not receive corrections after several automated reminders to the email address supplied for the corresponding author then we will assume that we have your approval for publication.
EJP is covered by the publisher's Early View service. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made subsequent to Early View publication. Early View articles can be cited and tracked by DOI.
Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://authorservices.wiley.com/bauthor for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Free access to the final PDF offprint of your article will be available via Author Services only. Please therefore sign up for Author Services if you would like to access your PDF offprint and enjoy the many other benefits the service offers.
Note to NIH Grantees
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate.
Submission of a manuscript will be held to imply that it contains original unpublished work and is not being submitted for publication elsewhere at the same time. The author must supply a full statement to the Editor-in-Chief about all submissions and previous reports that might be regarded as redundant or duplicate publication of the same or very similar work.
Conflicts of Interest
Authors are responsible for disclosing all financial and personal relationships between themselves and others that might be perceived by others as biasing their work. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist.
When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patients' names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution's or a national research council's guide for, or any national law on, the care and use of laboratory animals was followed. A statement describing explicitly the ethical background to the studies being reported should be included in all manuscripts in the Methods section. Ethics committee or institutional review board approval should be stated.
Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published in written descriptions, photographs and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Identifying details should be omitted if they are not essential but patient data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.
All persons designated as authors should qualify for authorship and all those who qualify should be listed. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article. Authorship credit should be based only on 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published. Conditions 1, 2 and 3 must all be met. Acquisition of funding, the collection of data or general supervision of the research group, by themselves, do not justify authorship. All others who contributed to the work who are not authors should be named in the Acknowledgements section.
Committee on Publication Ethics (COPE)
As a member of the Committee on Publication Ethics (COPE), adherence to these submission criteria is considered essential for publication in EJP; mandatory fields are included in the online submission process to ensure this. If, at a later stage in the submission process or even after publication, a manuscript or authors are found to have disregarded these criteria, it is the duty of the Editor-in-Chief to report this to COPE. COPE may recommend that action be taken, including but not exclusive to, informing the authors' professional regulatory body and/or institution of such a dereliction.
The website for COPE may be accessed at: http://www.publicationethics.org.uk
Faculty of 1000
An overly extensive overlap of a submitted paper with a publication in the database of the “Faculty of 1000” might lead to rejection of the paper.
Changes of Authorship
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts.
Before the accepted manuscript is published online: requests to add or remove an author, or to rearrange the author names, must be sent to the Editorial Manager or the Production Editor by the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Editorial Manager or the Production Editor to the corresponding author, who must follow the procedure as described above. Note that: (1) the Editorial Manager or Production Editor will inform the Editors of any such requests and (2) publication of the accepted manuscript online will be suspended until authorship has been agreed.
After the accepted manuscript is published online: any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.